Graphene oxide enhances alginate encapsulated cells viability and functionality while not affecting the foreign body response

Autor: Ciriza, Jesús, Saenz del Burgo, Laura, Gurruchaga, Haritz, Borràs i Serres, Francesc Enric, Franquesa, Marcella, Orive, Gorka, Hernández, Rosa Maria, Pedraz, José Luis, Universitat Autònoma de Barcelona

Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Drug Delivery, Vol 25, Iss 1, Pp 1147-1160 (2018)
Addi. Archivo Digital para la Docencia y la Investigación
instname
Drug Delivery
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

The combination of protein-coated graphene oxide (GO) and microencapsulation technology has moved a step forward in the challenge of improving long-term alginate encapsulated cell survival and sustainable therapeutic protein release, bringing closer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb9887dddc17fbb75335c8f03d148422
https://ddd.uab.cat/record/227917

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Graphene oxide enhances alginate encapsulated cells viability and functionality while not affecting the foreign body response.

Autor: Ciriza J; a Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine , CIBER-BBN , Vitoria-Gasteiz , Spain.; b NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy , University of the Basque Country, UPV/EHU , Vitoria-Gasteiz , Spain., Saenz Del Burgo L; a Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine , CIBER-BBN , Vitoria-Gasteiz , Spain.; b NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy , University of the Basque Country, UPV/EHU , Vitoria-Gasteiz , Spain., Gurruchaga H; a Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine , CIBER-BBN , Vitoria-Gasteiz , Spain.; b NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy , University of the Basque Country, UPV/EHU , Vitoria-Gasteiz , Spain., Borras FE; c REMAR-IVECAT Group, Health Science Research Institute Germans Trias i Pujol , Badalona , Spain.; d Department of Cell Biology, Physiology and Immunology , Universitat Autònoma de Barcelona , Bellaterra , Spain.; e Nephrology Service, Germans Trias i Pujol University Hospital , Badalona , Spain., Franquesa M; c REMAR-IVECAT Group, Health Science Research Institute Germans Trias i Pujol , Badalona , Spain.; e Nephrology Service, Germans Trias i Pujol University Hospital , Badalona , Spain., Orive G; a Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine , CIBER-BBN , Vitoria-Gasteiz , Spain.; b NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy , University of the Basque Country, UPV/EHU , Vitoria-Gasteiz , Spain., Hernández RM; a Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine , CIBER-BBN , Vitoria-Gasteiz , Spain.; b NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy , University of the Basque Country, UPV/EHU , Vitoria-Gasteiz , Spain., Pedraz JL; a Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine , CIBER-BBN , Vitoria-Gasteiz , Spain.; b NanoBioCel Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy , University of the Basque Country, UPV/EHU , Vitoria-Gasteiz , Spain.

Publikováno v: Drug delivery [Drug Deliv] 2018 Nov; Vol. 25 (1), pp. 1147-1160.